While doing the groundwork for this ICO, Orvium have ticked a lot of the boxes that an investor looks for when evaluating digital token opportunities.

There is a clear need for a platform to break the current oligopolistic market structure and bring ownership back to the content creators whilst providing true transparency.

Logical minds have been at work on the tokenomics as they are fairly priced and uncomplicated, without any obscure early bird bonus structures to muddy the waters. 

They have recruited a world class team to take on the challenge and have already established a strategic and tactical marketing plan to raise awareness and adoption of the new platform.

While still flying under the radar at this stage, with not even a set date for the public sale, over 1300 people have signed up for their Telegram channel which hints at prospective growing hype as the project moves forward.

This is, then, by all appearances a high calibre ICO, headed up by a first rate team with an excellent track record in their own respective fields.

An assessment of the risk attached to this project appears to relate more to external factors – specifically, whether there will be a disposition within the wider field of academia to gravitate to more modern approaches to publishing research such as the model proposed by Orvium – as opposed to internal factors which appear comparatively minimal when compared to the vast majority of ICOs currently operating in the market. 

Advantages.
1. Inefficiency in the field of academic papers and the existence of numerous intermediaries have long been questioned. Anyone who is engaged in academia can agree.
2. A project developed by researchers from the European particle physics laboratory CERN. A powerful team member.
3. It is different from other academic journal projects because it is focused on science and medical field.
A complementary point
1. It has a great weakness in marketing.
2. The roadmap is not so fast.
3. Recruitment of substantial participants is the most important issue.

"Positives ORV Tokens: The token is the primary currency that’s used on the platform. There is a transparent way to finance science and pay for the services. Users can get tokens for submitting their data, sharing data, and submit their manuscript for review. Journal Management: Journals that are published in the network that uses smart contracts to help manage it. This makes it easier for them to get them to produce high-quality journals towards other scientists in the network. Traceability: Orvium offers full traceability and allows users to select how their work is licensed and accessed by other users within the platform. The publications will have no delay, meaning that the journals will frequently be updated. As a result, this creates a collaborative environment. Negatives Limited Target Audience: Orvium is made only for people within the science industry. This can be difficult for the average investor to have interest in."

At Icon Partners, we think Orvium offers an interesting alternative to real-world issues that come with the current scientific article publishing process. The team and advisory board are really solid and can definitely deliver on the features mentioned in the whitepaper. Therefore, they are still far from the full release of the platform, which is always concerning when looking at ICOs. Finally, the fact that their token model includes a staking aspect will help reduce the velocity of ORV in the long run, increasing the demand for it, pushing its price upwards.

We encourage you to do your own research and come to your own conclusions when investing in an ICO. All the information in this review are either facts or ICON Partners’ opinions and should not be used as investment advice.

Orvium is a platform that aims to target the scientific publishing industry.The platform reduces costs while empowering scientists and facilitates a more free market when compared to the current system.

Market Penetration Potential: The problem with the centralized nature of the current scientific publication system is outlined clearly. Orvium plans to address current market inefficiencies and with their focus on scientific publications, there is potential for the project to gain considerable market share.

Solution Advantage: Manuscripts will be submitted to the platform (with the option to stake ORV tokens) in order to create a proof-of-existence and authorship which is stored on the (Ethereum) blockchain. It is stated that “user licensing is completely determined by the authors or owner”. Compared to similar projects, Orvium is specifically targeting the scientific publication sector.